Shanshan Wang

2.7k citations
82 papers · 2.1k indexed · h-index 25

Shanshan Wang

74 papers receiving 2.1k citations

Peers

Shanshan Wang
Comparison fields: 5 of 114
  • Cancer Research 669
  • Molecular Biology 1.2k
  • Biomaterials 183
  • Oncology 303
  • Hepatology 79
Replace Hong Chang with:
Hong Chang Taiwan
Serena Marchiò Italy
Tae Sup Lee South Korea
Yong Weon Yi South Korea
Bo Hu China
Shelia D. Thomas United States
Zhenjian Zhuo China
Chun‐Wei Peng China
Shuzhong Cui China
Lijun Ma China
Shanshan Wang relative to Hong Chang Taiwan Hong Chang's profile →
Citations per field
00.5×3.5×
Hong Chang · 1×
Citations per year

Countries citing papers authored by Shanshan Wang

Since Specialization
Citations

This map shows the geographic impact of Shanshan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanshan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanshan Wang more than expected).

Fields of papers citing papers by Shanshan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanshan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanshan Wang. The network helps show where Shanshan Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shanshan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shanshan Wang Line = papers co-authored together Shanshan Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20258
2 20252
3 20251
4 20250
5 20251
6 20241
7 20244
8 202311
9 20232
10 20235
11 20230
12 20227
13 20224
14 202242
15 20222
16 20220
17 20221
18
Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis
20201
19 202010
20 201224

About Shanshan Wang

Shanshan Wang is a scholar working on Cancer Research, Biotechnology, Molecular Biology, Oncology and Nutrition and Dietetics, having authored 82 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (11 papers), RNA Research and Splicing (9 papers), MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers), Circular RNAs in diseases (7 papers) and Food composition and properties (6 papers). The work is most often cited by research in Cancer Research (669 citations), Molecular Biology (1.2k citations), Biomaterials (183 citations), Oncology (303 citations) and Hepatology (79 citations). Shanshan Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Rongqin Huang, Chengyi Li, Min Qian, Xiang Zhou, Jianjun Jin, Bo Zuo, Zaiyan Xu, Ying Meng, Wuhui Song and Tingting Pan. Their work appears in journals such as International Journal of Biological Macromolecules, Cell Death and Disease, International Journal of Nanomedicine, Cells and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026